...
首页> 外文期刊>Nanotechnology >Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications
【24h】

Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications

机译:疏水性表面活性剂辅助一锅法合成的生物医学应用超细PEG包被的聚乳酸-乙醇酸共聚物纳米颗粒

获取原文
获取原文并翻译 | 示例
           

摘要

A novel method was developed for the one-pot synthesis of ultrafine poly(lactic-co-glycolic acid) nanoparticles (PLGA NPs), using an emulsion solvent evaporation formulation method. Using either cetyltrimethylammonium bromide (CTAB) or poly(ethylene glycol)-distearyl phosphoethanolamine (PEGPE) as an oily emulsifier during the emulsion process, produced PLGA particle sizes of less than 50nm, constituting a breakthrough in emulsion formulation methods. The yield of ultrafine PLGA NPs increased with PEGPE/PLGA ratio, reaching a plateau at around 85%, when the PEGPE/PLGA ratio reached 3:1. The PEGPE-PLGA NPs exhibited high drug loading content, reduced burst release, good serum stability, and enhanced cell uptake rate compared with traditional PLGA NPs. Sub-50nm diameter PEG-coated ultrafine PLGA NPs show great potential for invivo drug delivery systems.
机译:开发了一种通过乳液溶剂蒸发配制法一锅合成超细聚乳酸-乙醇酸纳米颗粒(PLGA NPs)的新方法。在乳化过程中,使用十六烷基三甲基溴化铵(CTAB)或聚(乙二醇)-二硬脂基磷酸乙醇胺(PEGPE)作为油性乳化剂,产生的PLGA粒径小于50nm,这是乳剂配制方法的一项突破。当PEGPE / PLGA比例达到3:1时,超细PLGA NPs的产量随PEGPE / PLGA比例的增加而增加,达到约85%的稳定水平。与传统的PLGA NPs相比,PEGPE-PLGA NPs具有较高的载药量,减少的突发释放,良好的血清稳定性和更高的细胞摄取率。直径小于50nm的PEG包被的超细PLGA NPs展示了体内药物递送系统的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号